rs4242549

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014629.4(ARHGEF10):​c.2144-174G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.597 in 152,064 control chromosomes in the GnomAD database, including 27,524 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27524 hom., cov: 33)

Consequence

ARHGEF10
NM_014629.4 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.165

Publications

4 publications found
Variant links:
Genes affected
ARHGEF10 (HGNC:14103): (Rho guanine nucleotide exchange factor 10) This gene encodes a Rho guanine nucleotide exchange factor (GEF). Rho GEFs regulate the activity of small Rho GTPases by stimulating the exchange of guanine diphosphate (GDP) for guanine triphosphate (GTP) and may play a role in neural morphogenesis. Mutations in this gene are associated with slowed nerve conduction velocity (SNCV). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
ARHGEF10 Gene-Disease associations (from GenCC):
  • autosomal dominant slowed nerve conduction velocity
    Inheritance: AD, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary peripheral neuropathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • peripheral neuropathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014629.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 8-1922790-G-A is Benign according to our data. Variant chr8-1922790-G-A is described in ClinVar as Benign. ClinVar VariationId is 1234308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.875 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014629.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARHGEF10
NM_014629.4
MANE Select
c.2144-174G>A
intron
N/ANP_055444.2O15013-5
ARHGEF10
NM_001438091.1
c.2147-174G>A
intron
N/ANP_001425020.1
ARHGEF10
NM_001308153.3
c.2144-174G>A
intron
N/ANP_001295082.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARHGEF10
ENST00000349830.8
TSL:1 MANE Select
c.2144-174G>A
intron
N/AENSP00000340297.3O15013-5
ARHGEF10
ENST00000518288.5
TSL:1
c.2216-174G>A
intron
N/AENSP00000431012.1O15013-6
ARHGEF10
ENST00000520359.5
TSL:1
c.2030-174G>A
intron
N/AENSP00000427909.1O15013-7

Frequencies

GnomAD3 genomes
AF:
0.597
AC:
90712
AN:
151944
Hom.:
27511
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.542
Gnomad AMI
AF:
0.581
Gnomad AMR
AF:
0.655
Gnomad ASJ
AF:
0.558
Gnomad EAS
AF:
0.897
Gnomad SAS
AF:
0.721
Gnomad FIN
AF:
0.662
Gnomad MID
AF:
0.633
Gnomad NFE
AF:
0.578
Gnomad OTH
AF:
0.588
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.597
AC:
90756
AN:
152064
Hom.:
27524
Cov.:
33
AF XY:
0.607
AC XY:
45108
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.542
AC:
22445
AN:
41438
American (AMR)
AF:
0.656
AC:
10026
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.558
AC:
1937
AN:
3470
East Asian (EAS)
AF:
0.897
AC:
4634
AN:
5168
South Asian (SAS)
AF:
0.720
AC:
3474
AN:
4824
European-Finnish (FIN)
AF:
0.662
AC:
7008
AN:
10582
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.578
AC:
39271
AN:
67982
Other (OTH)
AF:
0.591
AC:
1246
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1895
3790
5685
7580
9475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
13792
Bravo
AF:
0.595
Asia WGS
AF:
0.815
AC:
2832
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.4
DANN
Benign
0.59
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4242549;
hg19: chr8-1870956;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.